Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis

americanpharmaceuticalreviewDecember 19, 2018

Tag: FDA , BrainStorm , NurOwn , IND Application

PharmaSources Customer Service